Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

por McInnes, Iain B, Thompson, Liz, Giles, Jon T, Bathon, Joan M, Salmon, Jane E, Beaulieu, Andre D, Codding, Christine E, Carlson, Timothy H, Delles, Christian, Lee, Janet S, Sattar, Naveed
Publicado 2015

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study

por Schiff, Michael, Keiserman, Mauro, Codding, Christine, Songcharoen, Suthin, Berman, Alberto, Nayiager, Sauithree, Saldate, Cristina, Aranda, Richard, Becker, Jean-Claude, Nys, Marleen, le Bars, Manuela, Reed, Diane Moniz, Poncet, Coralie, Dougados, Maxime
Publicado 2011

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study

por Genovese, Mark C., Greenwald, Maria W., Gutierrez-Ureña, Sergio R., Cardiel, Mario H., Poiley, Jeffrey E., Zubrzycka-Sienkiewicz, Anna, Codding, Christine E., Wang, Annie, He, Weizhong, Amos, Rebecca, Vinueza, Raul, Wang, Xuegong, Garg, Jay P., Kivitz, Alan J.
Publicado 2019